Surgeon instructs teenage patient to perform 'heil Hitler salute,' recording reveals
Surgeon Kuldeep Stohr is being investigated for potential failures in 800 medical cases.
A surgeon suspended from the private Addenbrooke's Hospital in Cambridge,UK, asked a patient to perform a 'heil Hitler salute,' recordings released by ITV News last week revealed.
Surgeon Kuldeep Stohr is being investigated for potential failures in 800 medical cases. The latest recording was submitted as part of a complaint against her during her private practice. A Sky News investigation revealed that the trust may have downplayed concerns about Stohr as early as 2016 after an initial review found there may have been some issues with surgeries she performed.
A senior source at the hospital told Sky News that children were "severely permanently harmed" and "some of the cases are horrendous."
The patient, teenager Georgia D'Arcy, was instructed to perform the salute during a consultation, ITV News reported. Hospital management also reportedly heard Stohr deliver the instruction.
'If I say can you do this sort of movement for me, so like a heil Hitler or a heil Caesar, any pain when you do that?' Stohr is heard saying in the clip.
The 18-year-old reportedly broke her rib while on holiday in 2023, which was confirmed by a hospital in Dubai as well as the Cambridge institution.
When meeting with Stohr in January at the Nuffieldhospital, recordings revealed that the surgeon disputed that the rib was broken and grew increasingly frustrated with the family.
'You're still not letting it go, are you?' Stohr told the mother in response to requests for an MRI of the rib.
After the mother responded 'Pardon' to Stohr's comments, she responded 'You're not letting it go, are you. You've come here for an opinion, and how do you explain what I've just said? I'll get an MRI scan of what's relevant.'
'Okay, I'm getting angry actually, so I need to take just a deep breath,' she later told the mother. '... I just need to take a deep breath and channel my emotions, I'm sorry.'
In a statement, Ms Stohr told ITV: "I am not able to comment on individual cases due to my duty to protect patient confidentiality.
"I always strive to provide the highest standards of care to my patients. I am cooperating fully with the investigation, and it would not be appropriate to say more at this time."
A spokesperson for Nuffield Health stressed to the news site: 'We are aware of this complaint that dates back to January 2024. We took the complaint extremely seriously and conducted a thorough investigation at the time, ensuring that the patient's family received regular updates throughout the process.
'At Nuffield Health we hold ourselves to the highest standards of care and professionalism. The standard of care and conduct fell significantly below what we expect from any of the independent consultants who operate out of our hospitals, and we issued a full apology to the patient and their family.
'The consultant in question no longer practices at our Cambridge Hospital, and she hasn't operated here since October 2023.'
A hospital source told Sky News that much of the damage suffered by patients had been entirely "avoidable."
"The lives of children and families have been ruined," the source said. "Stohr destroyed people's lives by performing very poor surgery. She destroyed some hip joints."
In one case, a child was said to have been left with a broken arm for 11 days after Stohr failed to spot the injury.
Staff were "bullied and intimidated when they tried to raise concerns," and told there was no problem with Stohr's practice.
The surgeon was also said to have failed to consistently take CT scans after surgeries took place, despite post-surgical expectations for treating Developmental Dysplasia of the Hip.
One mother who approached Stohr for support in treating her son's painful birth defect on his foot was told by the surgeon, "There is no operation within my remits or that I can or am willing to perform, go away and leave it in the hands of God," the mother told Sky News.
While the child was treated at another hospital, his mother said, "I've been told that if she had done something sooner or even attempted to do something sooner, then he probably would have stood a bit better chance than what he's currently going through."
Sign up for the Health & Wellness newsletter >>
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Latest polling says if an election was held tomorrow Reform UK would win a majority
Since the local elections Reform UK has had no shortage of good polls. But a new one suggests Nigel Farage's party has a chance not only of winning the next election, but of claiming a decent Commons majority, too. In February, Reform topped a Sky News/YouGov poll for the first time, with Nigel Farage's party edging in front on 25%, Labour pushed into second on 24%, with the Tories on 21%. But a fresh one from Ipsos puts Reform on 34%, nine points ahead of Labour on 25%, with the Conservatives a distant third on 15%. While the other parties are flatlining, Reform appears to be pushing boundaries. Were these figures to be replicated across the country at a general election, with every constituency behaving the same way, then Reform could win as many as 340 seats, giving it a majority of 30, Sky News analysis suggests. Labour could be reduced to 176 seats, down 236 on last year's election, while the Tories would hit a record low of 12 seats. But polling should always be taken with a pinch of salt and with the firm acknowledgement that there is not an election coming any time soon. Conservative backbenchers might also tell you publicly that opinion polls are notoriously difficult to translate into seat numbers because voting percentages in individual constituencies can vary hugely from the overall average. But the truth is that the symbolism of Reform UK topping another poll is likely to be noticed by MPs from all parties, especially backbench Conservatives who have actively been hoping their leader, Kemi Badenoch, can help them climb the polls and bring the party back into public favour. Politics is a brutal game and when it comes to toppling underwhelming party leaders, the Tories are more ruthless than most. One wonders how many of these polls Mrs Badenoch's party will allow her to endure. Read more: This poll is also a warning to Labour. As the party approaches a year since its major victory, it will not have much to celebrate if these numbers are anything to go by. According to this survey, only 19% are satisfied with the job Sir Keir Starmer is doing as prime minister, with 73% dissatisfied. And the figure of 25% of voters intending to vote Labour is a level not seen since October 2019. While abstract to much of the public, polling can often shape not only the chatter inside Westminster but how and when plots by MPs begin. For Reform UK, this is a much-needed morale boost after a surprise resignation by their former Chairman Zia Yusuf, and then an almost immediate U-turn back into the party. And Kemi Badenoch - who said during her leadership campaign that the Conservatives needed to go back to first principles and that this would take time - will be wondering, seven-and-a-half months after winning the leadership, how much time she really has left.
Medscape
2 days ago
- Medscape
AI Enhances Prostate Cancer Detection in MRI Analysis
TOPLINE: In a large-scale diagnostic study, artificial intelligence (AI) assistance led to a superior improvement in prostate cancer detection on MRI, increasing diagnostic accuracy by 3.3% compared with unassisted readings. AI support enhanced both sensitivity (96.8%) and specificity (50.1%) at detecting clinically significant prostate cancer (csPCa). METHODOLOGY: Researchers conducted a diagnostic observer study in which 61 readers (34 experts and 27 non-experts) across 17 countries assessed 360 MRI examinations of men with prostate cancer (n = 360; median age, 65 years) with and without AI assistance. The AI system used in this study was curated and developed within the international Prostate Imaging-Cancer AI (PI-CAI) Consortium for the detection and diagnosis of csPCa. The primary objective was to assess whether AI-assisted csPCa diagnosis was superior to unassisted diagnosis at the patient level using the area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity at a Prostate Imaging Reporting and Data System threshold of 3 or more. TAKEAWAY: Among 360 men who were examined, 122 harboured csPCa. The AUROC was 0.916 with AI assistance vs 0.882 without, showing an improvement of 3.3% (P < .001). The sensitivity was 96.8% for AI-assisted assessments vs 94.3% for unassisted assessments, showing a significant improvement of 2.5% (P < .001). Likewise, the specificity was 50.1% for AI-assisted vs 46.7% for unassisted assessments, showing an improvement of 3.4%. Non-expert readers showed greater performance improvement with AI assistance than expert readers, achieving higher AUROC scores than those of unassisted experts. IN PRACTICE: "The findings of this diagnostic study suggest the potential of AI assistance in improving csPCa diagnosis when compared with unassisted assessments of biparametric MRI, with statistically significant improvements observed across AUROC, sensitivity, and specificity at a PI-RADS [Prostate Imaging Reporting and Data System] score of 3 or more. Notably, nonexpert readers demonstrated higher benefits from AI assistance compared with expert readers," the authors wrote. SOURCE: This study was led by Jasper J. Twilt, MSc, Minimally Invasive Image-Guided Intervention Center, Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands. It was published online on June 13, 2025, in JAMA Network Open. LIMITATIONS: The data included were retrospectively curated within the scope of PI-CAI, resulting in a mix of consecutive and sampled cohorts. The study's generalisability requires further validation across external cohorts with varying disease prevalence, image quality, and other clinical factors. The controlled online reading workstation environment differed from readers' native settings, potentially affecting diagnostic performance. This study did not assess workflow efficiency or the clinical applicability of performance improvements in real clinical settings. DISCLOSURES: This study received funding support from Health-Holland and the European Union's Horizon 2020. Several authors reported receiving personal fees and research funding and having other ties with various sources. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Medscape
2 days ago
- Medscape
First Scan for Suspected AxSpA: X-rays, MRI, or CT?
BARCELONA, Spain — Data from a prospective imaging study question the use of x-ray radiography first in the diagnostic workup of patients with suspected axial spondyloarthritis (axSpA), a practice that is currently a part of recommendations by the European Alliance of Associations for Rheumatology (EULAR). The study, which evaluated three different imaging pathways based on whether x-ray radiography, MRI, or CT of the sacroiliac joint (SIJ) was used first, found that the two latter approaches yielded a higher diagnostic efficacy than the radiograph-first approach. While just 13% of 30 people who were in the radiograph-first arm of the study were confirmed as having axSpA after the initial scan, 22% of 91 patients in the MRI-first and 30% of 84 people in the CT-first arms were given an axSpA diagnosis. X-ray, MRI, or CT first? Dominik Deppe, MD 'To x-ray or not to x-ray? What may sound somewhat philosophical, is a relevant question,' said study investigator Dominik Deppe, MD, who presented the findings at European Alliance of Associations for Rheumatology (EULAR) 2025 Annual Meeting. Deppe, a doctoral student in the Department of Radiology at Charité – Universitätsmedizin Berlin, Berlin, Germany, explained that although radiographs could show certain structural lesions, such as erosions, sclerosis, or ankylosis, and used relatively low levels of radiation, interpretation could be problematic. 'Even among experts, inter-reader reliability remains low,' Deppe said. MRIs are often performed if the results on radiography are negative or inconclusive. Such scans provide additional insights, he added, and can show both structural and inflammatory lesions, such as bone marrow edema. However, the high cost and low availability of MRI relative to radiography, however, were issues, he acknowledged. This is where CT could perhaps prove most useful. Although it's not part of the standard imaging pathway as yet, it is 'a gold standard for structural lesions,' Deppe said. He added: 'Historically, CT is considered to have high radiation exposure, but nowadays, we can perform CT with ultra-low dose techniques that allow us to reduce radiation exposure to a level that is comparable, or even less, compared to conventional x-rays.' Strategies Compared and Results The study included 205 people with suspected axSpA, who were randomly allocated into one of three arms: 30 to a radiograph-first or 'standard' arm, 91 to an MRI-first arm, and 84 to a CT-first arm. Scans were designated positive or negative by the consensus of two specialized musculoskeletal radiologists who were blinded to the clinical data. A positive result was defined as clear signs of structural or inflammation suggestive of axSpA and no further imaging was done. Those with negative scans underwent a subsequent scan with another method; those in the radiograph-first arm had an MRI scan and then a CT scan, those in the MRI-first arm had a CT scan, and those in the CT-first arm had an MRI scan. The results are preliminary because the study is ongoing and results from the final diagnosis by a rheumatologist are not yet available, Deppe said. He reported that in the radiograph-first arm, 26 (87%) people had a negative scan and then had an MRI scan. This was positive in three (11%) and negative in 23 (88%) of people. None of the people with a negative MRI scan had a positive CT scan. In the MRI-first arm, scans were positive in 20 (22%) and negative in 71 (78%) of people. Again, CT added no further cases among the people who were also MRI-negative. Finally, in the CT-first arm, there were 25 (30%) positive and 59 (70%) negative scans. MRI performed in the CT-negative patients detected two (3%) additional cases of confirmed axSpA. Deppe said: 'Our standard approach, [which] we're using right now, has the lowest diagnostic efficacy, compared to the MRI-first and CT-first approach.' Patient Characteristics Information about patient demographics were not presented, however, which prompted Uta Kiltz, MD, a senior rheumatologist at Rheumazentrum Ruhrgebiet, Herne, Germany, to ask for clarification and about the study design. 'Can you give some information about the population you included in the study?' she asked. 'I think we need to have some more context about the decision-making process to really understand the results.' Deppe responded that the patients had been referred with the suspicion and not confirmed diagnosis of axSpA and had been randomized through a third party into the three different imaging arms. Topline patient demographics had been given in the abstract, which stated that the mean age of the population studied was 38 years (SD, 10.58 years) and just over half (58%) were women. Around half (53%) of the study population was HLA-B27 positive. The mean C-reactive protein level was 3.66 mg/L, and the mean BMI was 25.57. The mean duration of back pain was around 8 years, and 70.6% of people had signs of inflammatory back pain. Questions Raised Several discussants raised concerns about the study design and the interpretation of these early findings. Eric Ruderman, MD, of Northwestern University Feinberg School of Medicine, Chicago, questioned why all patients did not receive all three imaging modalities: 'Ultimately, you don't know the diagnostic specificity of the [ultra] low-dose CT. Why didn't you do all three images in each patient, so that you can actually make a comparison once you have the confirmed diagnosis?' Deppe replied that the team wanted to be pragmatic: 'We wanted to evaluate the clinical settings where the patient does not undergo every imaging, but if we found positive results, as in the clinical practice, we don't need further imaging, and this is something we want to demonstrate in the study.' Xenofon Baraliakos, MD, head of rheumatology at the Rheumazentrum Ruhrgebiet, and the new president of EULAR, raised concerns about potential false positives: 'What happens if the x-ray is it was falsely positive? Have you been able to check for that?' Deppe acknowledged the limitation: 'I think this is something we have to do when we have the final diagnosis by the rheumatologist, to see whether we missed or misinterpreted some of the images.' This study was independently supported. Deppe had no conflicts of interest. The commentators were not involved in the study.
